Distribution and standardization of antihypertensive medications in the pharmacy of State University of Maringá (FEN-UEM)
Abstract
With the objective of standardizing antihypertensive drugs in FEN-UEM, the acquisition and consumption of these drugs were analyzed. The data were collected starting from the invoices of purchase of the pharmaceutical antihypertensives specialties (EAH) for the referred pharmacy. The study was carried out in the period of January 1st, 1990 trough December 31st 1994. The amount of acquired EAH, active substance and pharmacological class were analyzed. The FEN-UEM acquired 4,751 EAH in this period. There was increased in the acquisition of angiotensin-converting enzyme inhibitors (63,6%) and reduction for diuretics (54,2%), beta-blockers (36,3%), alpha central agonists (64,3%) and associations (28,2%). The acquisition of calcium antagonists was constant in this period. The data suggest that the acquisition and distribution of these medications are correlated with the current therapeutics, allowing to evaluate the profile of antihypertensive drugs in FEN-UEM and to standardize the EAH to be distributed by the pharmacies.Downloads
Download data is not yet available.
Published
2008-07-17
How to Cite
Tasca, R. S., & Cuman, R. K. N. (2008). Distribution and standardization of antihypertensive medications in the pharmacy of State University of Maringá (FEN-UEM). Acta Scientiarum. Health Sciences, 21, 379-382. https://doi.org/10.4025/actascihealthsci.v21i0.4451
Issue
Section
Health Sciences
DECLARATION OF ORIGINALITY AND COPYRIGHTS
I Declare that current article is original and has not been submitted for publication, in part or in whole, to any other national or international journal.
The copyrights belong exclusively to the authors. Published content is licensed under Creative Commons Attribution 4.0 (CC BY 4.0) guidelines, which allows sharing (copy and distribution of the material in any medium or format) and adaptation (remix, transform, and build upon the material) for any purpose, even commercially, under the terms of attribution.
Read this link for further information on how to use CC BY 4.0 properly.